Ozempic is a brand-name, FDA-approved pre-filled pen manufactured by Novo Nordisk at fixed doses (0.25, 0.5, 1.0, and 2.0 mg)
The drug works by promoting insulin release, delaying digestion, and increasing the transit time of food in the gastrointestinal tract
Key differences: Rybelsus is a GLP-1 receptor agonist that provides superior A1C reduction (1.3% vs 0.9%) and greater weight loss, while Jardiance is an SGLT2 inhibitor that offers superior cardiovascular protection (38% CV death reduction) and kidney benefits
In that moment, we have not failed the dose the dose has not fully accumulated yet
Common experience points include: Early weeks may bring reduced appetite and earlier fullness Some people notice less interest in heavy or greasy foods Weight loss often becomes clearer after dose increases and consistent routines Hydration and protein help reduce fatigue and support lean mass Strength training supports metabolism and improves body composition Weekly injections are usually simple and quick